ARCHIVES

FDA Approves Xeloda For Breast Cancer Treatment.

This article is from The Cancer Letter archive.

Vol. 27 No. 35 | September 28, 2001

Download PDF Visit The Full Archive

Related Articles

Advocacy Group Urges FDA to Sift Through Avastin Glioblastoma Data—Agency Accepts

June 14, 2013

ABMT Trials Unlikely To show Clean Benefit for Breast Cancer; Data Release Debated

March 12, 1999

In Brief: House, Senate Pass Rescision Bills; NCI Compromise Figure Probably About $10 Million Cut For FY 1981

May 29, 1981

CTAC Discussion, Group Chairs Comment

December 17, 2010

Eight Scientists Receive $800,000 From Milken

January 12, 1990

Henderson Committee Final Recommendation Made On P01s

February 10, 1984